The first and only fully translational rehabilitation hospital in the world.
Shirley Ryan AbilityLab is the global leader in physical medicine and rehabilitation for adults and children with the most severe, complex conditions — from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment. Our goal? To provide the best opportunity for each patient’s best outcome. We have proven that applying (or “translating”) scientific research for use in physical medicine and rehabilitation makes better recoveries not only possible, but faster.
On March 25, 2017, Rehabilitation Institute of Chicago (RIC) became Shirley Ryan AbilityLab and opened the doors to this $550 million, 1.2-million-square-foot cutting-edge inpatient and outpatient facility. The building’s flowing architecture structurally compels collaboration between disciplines in real time. There are no boundaries — physical or philosophical — between clinicians and researchers as they work together with patients to recover impaired or lost functions and abilities.
We’ve been ranked No. 1 in our field by U.S. News & World Report every year since 1991. Our physicians and therapists are leaders in their specialties, and our nursing excellence has earned a continuous record of Magnet status held by only 2% of U.S. hospitals.
In our flagship hospital, clinicians, scientists, innovators and technologists work with patients undergoing intensive post-traumatic and disease-related functional (physical and cognitive) rehabilitation.
High-quality clinical care is provided in 262 state-of-the-art patient rooms. Our translational ability labs, which are applied research and therapeutic spaces, focus on specific human functions: Think + Speak Lab, Legs + Walking Lab, Strength + Endurance Lab and Arms + Hands Lab. There is also a separate Pediatric Lab.
Here, more than 250 studies are under way in the areas of biomedical science with extraordinary promise, including neuroscience, bionic medicine, molecular and cellular biology, robotics, musculoskeletal medicine, pharmacotherapeutics and technology transfer, among others.